Tag Archives: qiagen

Efficient rRNA removal from mammalian, bacterial, plant and yeast samples for RNA-seq and metatranscriptomics studiesThe more effective your rRNA removal strategy, the greater your ability to achieve usable reads in RNA-seq. Not only does rRNA...

Advances in diabetes research facilitated by QIAseq UPX 3′ Transcriptome technology Chronic exposure to environmental arsenic is associated with several diseases, including diabetes mellitus. Join our live...

Are you spending hours trying to optimize your RNA-seq workflow but still struggling to achieve consistent, high-quality, on-target reads? High levels of ribosomal RNA (rRNA) could be jeopardizing your RNA-seq workflow, compromising your ability to detect low-abundance mRNA transcripts…

RNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving high-performance library preparation can prove essential to maximizing your discoveries. In this webinar, you ...

Gene expression analysis using next-generation sequencing (NGS) has advantages in throughput, sensitivity and accuracy over qPCR and microarray methods. However, current limitations with library preparation strategies and access to data analysis often makes RNA-seq unnecessarily laborious and confusing. This live ...

RNA-seq analysis of human breast cancer data

Performing qPCR-based profiling of microRNA from single cells or small cell numbers? Our July 12 webinar will definitely help you get the most out of your precious samples! The webinar focuses on a new, streamlined process for differential expression profiling based on ...

RNA-seq Explorer Solution generates clear insights for cancer ‘omics’ analyses Hilden, Germany, and Germantown, Maryland, April 14, 2016 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced introduction of its unique RNA-seq Explorer Solution, a bioinformatics-driven approach to ...

Sample to Insight workflows deliver more efficient, accurate gene expression profiling Hilden, Germany, and Germantown, Maryland, February 11, 2016 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the introduction of more than 170 new QIAseq Targeted RNA ...

  Infection by West Nile Virus (WNV) is a worldwide public health concern, being the most common cause of epidemic viral encephalitis in USA, yet the viral pathogenesis is not well understood. Using QIAGEN Ingenuity Pathway Analysis’ features, we were ...